GURU.Markets stock price, segment price, and overall market index valuation
The company's share price iSpecimen Inc.
iSpecimen is an online platform that connects scientists with suppliers of biological samples for research. Its stock price is a bet on its platform becoming the standard in this niche. The chart reflects the slow path to commercialization and the need for funding.
Share prices of companies in the market segment - It med
iSpecimen is a technology company that operates an online platform that connects researchers with biobanks to obtain human tissue and fluid samples. We've categorized it as "IT in Medicine." The chart below shows how the market values companies accelerating medical research.
Broad Market Index - GURU.Markets
iSpecimen is a technology company that operates an online platform connecting researchers with biospecimens (tissue, blood) for medical research. As a unique player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with iSpecimen's performance.
Change in the price of a company, segment, and market as a whole per day
ISPC - Daily change in the company's share price iSpecimen Inc.
The daily fluctuations of iSpecimen Inc. shares reflect the volatility of the biomedical sample market. This metric is a measure of the sensitivity of pharmaceutical and biotech companies to R&D spending.
Daily change in the price of a set of shares in a market segment - It med
iSpecimen Inc. is an online marketplace for biospecimens. This chart highlights the high volatility of the healthcare sector. Comparing it to ISPC, whose business serves as a barometer for R&D, helps to appreciate its unique profile.
Daily change in the price of a broad market stock, index - GURU.Markets
iSpecimen created an online platform that connects researchers with biospecimens (tissue, blood). Its business serves as a barometer of R&D activity in the pharmaceutical industry. Its stock price is an indicator of innovation activity, influencing the overall market environment.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization iSpecimen Inc.
iSpecimen Inc.'s year-over-year performance tells the story of its unique role in biomedical research. Its 12-month market cap growth reflects pharmaceutical companies' demand for its online platform, which enables them to find and purchase human biomaterial samples needed for the development of new drugs and diagnostic tests.
Annual dynamics of market capitalization of the market segment - It med
iSpecimen Inc. operates an online marketplace that connects researchers with biospecimens. Its business serves as the infrastructure foundation for medical research. The chart below illustrates how its unique niche and dependence on pharmaceutical companies' R&D budgets influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
iSpecimen, with its online biosample platform, is a unique bet on the growth of pharmaceutical R&D. Its performance relative to the market is a testament to whether it can become a standard for scientists. Successful scaling and network effects will allow it to grow faster than the market, regardless of economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization iSpecimen Inc.
iSpecimen operates an online platform for procuring biospecimens for research. Its business depends on R&D spending in the pharmaceutical and biotech industries. Monthly fluctuations in its price reflect the growth in the number of transactions on its platform and the demand for samples.
Monthly dynamics of market capitalization of the market segment - It med
iSpecimen is an online platform that connects scientists working on medical research with suppliers of biospecimens (tissue, blood) needed for their work. The graph below illustrates the dynamics of the medical technology sector, where access to high-quality data and samples is critical.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
iSpecimen is an online marketplace connecting researchers with biospecimen suppliers. Demand for its services depends on activity in biotech and pharmaceutical research. Shares can move with the innovation cycle in life sciences, which doesn't always align with overall market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization iSpecimen Inc.
iSpecimen is an online platform that connects researchers with biospecimens (tissue, blood). Its weekly stock price reflects R&D spending in the pharmaceutical and biotech industries.
Weekly dynamics of market capitalization of the market segment - It med
iSpecimen is a technology platform connecting researchers with biospecimens. The chart shows how this unique company's stock performs compared to the medical IT sector. Is its volatility a consequence of its innovative model or a general trend for biotech service companies?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
iSpecimen Inc., a medical IT platform, sits at the intersection of the defensive medical sector and the volatile tech sector. The chart will reveal which of these forces dominates. Is it moving like a stable medical company or a risky tech startup?
Market capitalization of the company, segment and market as a whole
ISPC - Market capitalization of the company iSpecimen Inc.
iSpecimen Inc.'s market cap tells the story of its creation as a marketplace for biomedical samples. The chart shows how investors value its platform, which connects researchers with the biomaterials they need. This is a venture bet on the company becoming a vital part of the R&D infrastructure.
ISPC - Share of the company's market capitalization iSpecimen Inc. within the market segment - It med
iSpecimen created an online platform that connects researchers in need of human tissue samples with hospitals and biobanks that can provide them. Its market share in the medical IT sector reflects its unique role as a scientific marketplace. The company's size reflects its bet that its platform will become the standard for biomedical research.
Market capitalization of the market segment - It med
iSpecimen has created an online platform for purchasing biospecimens for research. How big is this scientific backbone? The graph below shows the overall market capitalization of the medical IT sector. Its growth reflects the importance of access to high-quality biospecimens for the development of new drugs and diagnostic tests.
Market capitalization of all companies included in a broad market index - GURU.Markets
The iSpecimen chart shows how the market values a scientific intermediary platform. The company's market cap, which connects researchers with suppliers of biospecimens (tissue, blood), is betting on accelerating medical development. This diagram illustrates how a marketplace can operate in such a complex field as biotech.
Book value capitalization of the company, segment and market as a whole
ISPC - Book value capitalization of the company iSpecimen Inc.
For iSpecimen, an online marketplace for biospecimens for research, book value is its tangible assets, primarily its IT platform connecting suppliers and scientists, as well as its offices. The chart below shows how the company has invested in its technological foundation.
ISPC - Share of the company's book capitalization iSpecimen Inc. within the market segment - It med
iSpecimen Inc. is a technology platform connecting researchers with biospecimens. While it does not own laboratories, its physical assets are the IT infrastructure and operations centers that serve as the control room for this unique network. The graph shows how its lightweight model compares to traditional biobanks.
Market segment balance sheet capitalization - It med
iSpecimen is a marketplace for biospecimens. Compared to the capital-intensive healthcare sector, it's asset-light. The industry's asset chart reflects the value of laboratories. iSpecimen doesn't own them. Its asset is an IT platform that connects scientists with suppliers.
Book value of all companies included in the broad market index - GURU.Markets
iSpecimen's assets are not laboratories, but an online marketplace that connects scientists in need of human biomaterial samples (tissue, blood) with clinics that can provide them. The book value reflects the IT infrastructure that underpins this unique platform.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - iSpecimen Inc.
iSpecimen is an online platform that connects scientists who need biospecimens (tissue, blood) with organizations that provide them. It doesn't operate its own laboratories. Its value lies in its platform and network. The chart shows how the market values its role as an intermediary accelerating medical research.
Market to book capitalization ratio in a market segment - It med
iSpecimen operates an online platform that connects researchers with biospecimens (tissue, blood). It's a unique technological platform. The chart shows that the market values its role as an important intermediary in biomedical research significantly more than its tangible assets.
Market to book capitalization ratio for the market as a whole
iSpecimen is an online marketplace for biospecimens, connecting researchers with suppliers. The company's value lies in its network and technology platform, not in its physical labs. This chart demonstrates how investors value business models based on network effects compared to traditional companies.
Debts of the company, segment and market as a whole
ISPC - Company debts iSpecimen Inc.
iSpecimen operates an online platform that connects researchers with biospecimens (tissue, blood) needed for scientific research. Such a technology platform requires capital for IT infrastructure development and marketing to attract both sample suppliers (hospitals) and buyers (pharmaceutical companies).
Market segment debts - It med
iSpecimen is an online platform that connects scientists working in biomedical research with the biospecimens (tissue, blood) needed for their work. As a technology intermediary, the company bears the costs of platform development and marketing. This chart shows how it finances its operations.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio iSpecimen Inc.
iSpecimen Inc. operates an online platform for purchasing biospecimens for research. This chart shows the financial structure of the company, which bridges science and business. Incurring debt during the platform's scaling phase could be risky if transaction growth doesn't outpace interest payments.
Market segment debt to market segment book capitalization - It med
iSpecimen operates an online platform that connects researchers with the biospecimens (tissue, blood) they need for their work. This is an important niche in medical science. The chart shows the overall debt burden in the IT sector, which helps assess how the company finances its unique technology platform and expanding sample supplier network.
Debt to book value of all companies in the market
iSpecimen Inc. is an online platform connecting researchers with biospecimen suppliers. It's a unique model that doesn't require laboratory ownership. This chart, reflecting the debt of capital-intensive sectors, highlights iSpecimen's role as a technology intermediary, whose value lies in its network rather than physical assets, which underlies its lightweight financial structure.
P/E of the company, segment and market as a whole
P/E - iSpecimen Inc.
This chart shows the valuation of iSpecimen, a technology platform connecting researchers with biospecimen suppliers. The price-to-earnings ratio (if any) will reflect its network effect. This is a bet that its marketplace will become an indispensable tool for pharmaceutical and biotech companies.
P/E of the market segment - It med
iSpecimen is a technology company that operates an online marketplace for sourcing, purchasing, and acquiring human biospecimens (tissue, blood) for scientific and medical research. This chart shows the average valuation for the sector, helping to understand how the market values this unique platform that accelerates scientific discovery.
P/E of the market as a whole
iSpecimen operates an online platform that connects researchers with biospecimens (tissue, blood) needed for scientific research. Its business depends on the volume of R&D in the pharmaceutical and biotech industries. This general sentiment trend influences biotech funding, but for iSpecimen, the long-term trend toward personalized medicine is more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company iSpecimen Inc.
iSpecimen operates an online marketplace that connects scientists seeking biospecimens (tissue, blood) with healthcare organizations that can provide them. This graph reflects the expected growth of biopharmaceutical research. Future profitability depends on the number of transactions on the platform and the expansion of the supplier network.
%20P%2FE%20iSpecimen%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-iSpecimen-Inc.&v=1772572105090 "Chart of the company's future (projected) P/E iSpecimen Inc.")
Future (projected) P/E of the market segment - It med
iSpecimen is an online platform that connects scientists in need of biospecimens (tissue, blood) with organizations that can provide them. Its valuation relative to other medtech companies reflects investors' views on its unique business model, betting that its platform will become a key tool for medical research.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-It-med&v=1772572105111 "Future (projected) P/E graph of the market segment - It med")
Future (projected) P/E of the market as a whole
iSpecimen is an online platform that connects researchers from pharmaceutical and biotech companies with human tissue and biofluid samples. The company's business depends on activity in biomedical research. This chart reflects the overall sentiment in the healthcare sector, showing how actively investors and companies are investing in R&D.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772572105118 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit iSpecimen Inc.
iSpecimen has created an online platform that connects scientists seeking human tissue samples for research with hospitals and biobanks that can provide them. Financial results reflected here are based on biomedical research activity and transaction volumes on its marketplace.
Profit of companies in the market segment - It med
iSpecimen Inc. operates an online marketplace that connects scientists working on medical research with human biospecimens. This chart shows the overall profitability of the medical IT and biotech sector, helping to understand the commercial viability of the platform model in such a highly specialized and important niche.
Overall market profit
iSpecimen has created an online platform that connects researchers with the biospecimens (tissue, blood) needed for their work. Demand for its services depends on the level of R&D funding in the pharmaceutical and biotech industries. This overall profit curve influences corporate R&D budgets, but government funding also plays a significant role.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company iSpecimen Inc.
iSpecimen operates an online platform that connects researchers with biospecimens (tissue, blood) needed for medical research. The company's future profits depend on R&D spending in the pharmaceutical and biotech industries. This chart shows analysts' expectations for biorepository market growth and demand for its unique services.
%20profit%20of%20the%20company%20iSpecimen%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-iSpecimen-Inc.&v=1772572105202 "Graph of future (projected) profit of the company iSpecimen Inc.")
Future (predicted) profit of companies in the market segment - It med
iSpecimen has created an online platform that connects researchers from pharmaceutical and biotech companies with human biomaterial samples (tissue, blood) from hospitals and laboratories. This graph shows forecasts for the healthcare IT sector, illustrating the importance of access to high-quality data and samples for accelerating medical research and development.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-It-med&v=1772572105212 "Graph of future (predicted) profits of companies in a market segment - It med")
Future (predicted) profit of the market as a whole
This shows expectations for medical research spending. For iSpecimen, a biospecimen platform, this is a key factor. Economic growth allows pharmaceutical companies and research institutes to increase R&D budgets, which increases demand for their services. A recession leads to a reduction in research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772572105222 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - iSpecimen Inc.
iSpecimen has created an online marketplace for biospecimens, connecting researchers with the materials they need. This figure reflects investors' estimates of its potential revenue, betting that its platform will become the standard in biomedical research.
P/S market segment - It med
iSpecimen operates an online marketplace that connects scientists working on medical research with the biospecimens (tissue, blood) needed for their work. This chart shows the average valuation in the medical IT sector. It reflects how highly investors value iSpecimen's unique platform, which accelerates medical discovery.
P/S of the market as a whole
iSpecimen Inc. operates an online marketplace that connects pharmaceutical and academic researchers with the biospecimens (e.g., tissue, blood) they need for their research. Revenue is generated through commissions. This chart helps assess the market's value for this unique platform that accelerates medical research.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company iSpecimen Inc.
iSpecimen is an online marketplace that connects scientists with biospecimens (tissue, blood) needed for research. Future revenue depends on the growth of R&D in the pharmaceutical and biotech industries. The chart demonstrates investors' belief that this platform will become a key tool for accelerating scientific discovery.
%20P%2FS%20iSpecimen%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-iSpecimen-Inc.&v=1772572105276 "The graph of the company's future (projected) P/S iSpecimen Inc.")
Future (projected) P/S of the market segment - It med
iSpecimen Inc. operates an online marketplace that connects scientists conducting medical research with biobanks and hospitals where samples of human tissue, blood, and other biomaterials can be obtained. This chart shows how the market evaluates the potential of this unique platform compared to other healthcare IT companies.
%20P%2FS%20market%20segment%20graph%20-%20It%20med&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-It-med&v=1772572105287 "Future (projected) P/S market segment graph - It med")
Future (projected) P/S of the market as a whole
This chart reflects expectations for the biomedical research market. For iSpecimen, an online platform connecting researchers with biospecimen suppliers, it serves as a barometer of R&D activity. Market optimism allows pharmaceutical companies and research institutes to increase research budgets, driving demand for the platform's services.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772572105333 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales iSpecimen Inc.
iSpecimen created an online platform that connects researchers from pharmaceutical and biotech companies with the human biospecimens (tissue, blood) needed for their work. This chart shows revenue from fees for each transaction on the platform. The increase in revenue reflects the increasing number of studies and the demand for high-quality biospecimens.
Sales of companies in the market segment - It med
iSpecimen Inc. operates an online marketplace that connects scientists working on medical research with human biospecimens. This graph illustrates the growth of the medical IT market. iSpecimen accelerates scientific discovery by making access to essential samples simpler and more efficient, which is critical for the entire biomedical industry.
Overall market sales
iSpecimen Inc. operates an online platform that connects researchers with the biospecimens they need for their work. Demand for its services depends on funding levels for biomedical research. The overall economic situation, shown in this graph, influences R&D budgets, which are iSpecimen's source of income.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company iSpecimen Inc.
iSpecimen has created an online platform that connects researchers (from pharmaceutical companies and academia) with suppliers of biospecimens (e.g., tissue and blood samples) needed for scientific research. This graph reflects analysts' expectations for the growth of the biorepository market and the demand for human biospecimens to accelerate medical discovery.
%20sales%20of%20the%20company%20iSpecimen%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-iSpecimen-Inc.&v=1772572105390 "Schedule of future (projected) sales of the company iSpecimen Inc.")
Future (projected) sales of companies in the market segment - It med
iSpecimen operates an online platform that connects researchers with the biospecimens they need for their work. This graph illustrates expectations for the medical IT sector. It reflects the growing need for data and biomaterials to accelerate medical research, a niche market for iSpecimen.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-It-med&v=1772572105394 "Schedule of future (projected) sales of companies in the market segment - It med")
Future (projected) sales of the market as a whole
iSpecimen Inc. operates an online platform that connects researchers in need of human biomaterial samples with sample suppliers. Demand for its services depends on the level of biomedical research activity. This dynamic, reflecting the overall economic situation, influences R&D funding in the pharmaceutical and biotech industries, which drives iSpecimen.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772572105450 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality iSpecimen Inc.
iSpecimen has created an online platform that connects researchers with suppliers of biospecimens (e.g., tissue, blood). This chart shows the company's profitability as a research intermediary. The company's profit comes from a commission on each transaction, and its success depends on expanding its network of both suppliers and buyers of biospecimens.
Market segment marginality - It med
iSpecimen has created an online platform that connects researchers with biospecimens (tissue, blood) needed for scientific research. The profitability of this unique business model depends on the network's scale and transaction fees. This chart, showing the average profitability in the medical IT sector, helps assess the potential and effectiveness of the iSpecimen platform.
Market marginality as a whole
iSpecimen is an online marketplace that connects researchers with biospecimens (tissue, blood, etc.) needed for scientific research. This overall market revenue curve indirectly impacts R&D budgets. However, for iSpecimen, growth in the biotech and pharmaceutical sectors is more important, ensuring stable demand for its unique platform.
Employees in the company, segment and market as a whole
Number of employees in the company iSpecimen Inc.
iSpecimen has created an online platform that connects scientists in need of human tissue and biofluid samples with medical institutions that can provide them. This graphic shows the team that runs this unique marketplace, accelerating medical research.
Share of the company's employees iSpecimen Inc. within the market segment - It med
iSpecimen has created an online platform connecting researchers with biospecimens (tissue, blood). This chart shows the percentage of biobanking, logistics, and IT specialists working at the intersection of medicine and technology that the company attracts. It reflects its unique role as an aggregator and hub of expertise to accelerate medical research.
Number of employees in the market segment - It med
iSpecimen is an online marketplace that connects scientists in need of human tissue and biofluid samples with organizations that can provide them. This graph illustrates how digital platforms are penetrating science, accelerating research and creating a new niche at the intersection of IT, logistics, and medicine, requiring unique specialists.
Number of employees in the market as a whole
iSpecimen Inc. has created an online platform for biomedical samples, digitizing a portion of scientific activity. This graph reflects growth in high-tech sectors, where platform solutions improve efficiency. iSpecimen accelerates research across the biopharmaceutical industry, indirectly contributing to the creation of new scientific jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company iSpecimen Inc. (ISPC)
iSpecimen is a technology platform (marketplace) connecting researchers with biospecimens (tissue, blood). This chart represents the pure intellectual capital value of iSpecimen. iSpecimen doesn't own any laboratories; it owns the platform. The chart shows how highly the market values this technology network and its scalability potential per employee.
%20of%20the%20company%20iSpecimen%20Inc.%20(ISPC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-iSpecimen-Inc.-ISPC&v=1772572106127 "Chart of market capitalization per employee (in thousands of dollars) of the company iSpecimen Inc. (ISPC)")
Market capitalization per employee (in thousands of dollars) in the market segment - It med
iSpecimen has created an online platform for researchers that allows them to find human tissue samples. It's a unique business model at the intersection of medicine and IT. The chart shows how the market values a team capable of managing such a complex platform. A high score may indicate the advanced technology and scalability of their business.
%20by%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-It-med&v=1772572106156 "Market capitalization per employee (in thousands of dollars) by market segment - It med")
Market capitalization per employee (in thousands of dollars) for the overall market
iSpecimen Inc. operates an online marketplace for finding and purchasing biospecimens for research. This chart shows the average market value generated by one specialist, illustrating how this technology platform can transform scientific research.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772572106222 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company iSpecimen Inc. (ISPC)
iSpecimen is an online marketplace that connects researchers who need biospecimens (tissue, blood) with labs that have them. This is the platform model. This graph shows how efficient the platform is. It reflects the net profit (commissions) generated by each employee from facilitating these transactions.
%20Chart%20iSpecimen%20Inc.%20(ISPC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-iSpecimen-Inc.-ISPC&v=1772572106299 "Company Profit Per Employee (in thousands of dollars) Chart iSpecimen Inc. (ISPC)")
Profit per employee (in thousands of dollars) in the market segment - It med
iSpecimen Inc. operates an online platform that connects researchers with biospecimens (tissue, blood) needed for scientific research. It is a technology business at the intersection of medicine and IT. The data in this chart demonstrates how effectively a small team can manage a complex logistics and information network, generating value for the pharmaceutical industry per employee.
%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-It-med&v=1772572106373 "Chart of profit per employee (in thousands of dollars) in the market segment - It med")
Profit per employee (in thousands of dollars) for the market as a whole
iSpecimen (ISPC) operates an online marketplace that connects scientists (from pharmaceutical and biotech) in need of samples (blood, tissue) with hospitals and laboratories that have them. It is an IT/MedTech platform. This chart shows the average market profitability per employee. It helps assess how effective ISPC's IT model (intermediary platform) is in generating profit per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772572106415 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee iSpecimen Inc. (ISPC)
iSpecimen is a technology platform that connects researchers with biospecimens (e.g., tissue, blood). This graph demonstrates the effectiveness of a unique marketplace model in biotech. It illustrates how a company, without owning the samples, generates revenue by connecting supply and demand.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-iSpecimen-Inc.-ISPC&v=1772572106444 "Sales chart per company employee iSpecimen Inc. (ISPC)")
Sales per employee in the market segment - It med
iSpecimen operates an online marketplace that connects researchers (pharmaceutical companies) with biospecimen suppliers (hospitals). It's an IT platform. This chart shows the average revenue per employee in this segment. It helps evaluate how effectively the iSpecimen team monetizes its unique B2B platform compared to its competitors.
Sales per employee for the market as a whole
iSpecimen is a technology platform (marketplace) that connects scientists who need biospecimens (tissue, blood) with healthcare organizations that have them. This graph shows how effectively their team (sales, IT specialists) generates revenue (commissions) from each transaction on their unique B2B platform.
Short shares by company, segment and market as a whole
Shares shorted by company iSpecimen Inc. (ISPC)
iSpecimen operates an online marketplace that connects researchers (biotech, pharmaceutical) with suppliers of human biospecimens (blood, tissue). It's an interesting, but unprofitable, model. This chart shows the odds that the company will burn through all its money trying to scale its platform and fail to achieve profitability.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-iSpecimen-Inc.-ISPC&v=1772572106554 "Short Shares Chart for the Company iSpecimen Inc. (ISPC)")
Shares shorted by market segment - It med
iSpecimen Inc. operates an online marketplace that connects biopharmaceutical companies and researchers with biospecimens (tissue, blood) needed for R&D. This chart shows the overall short position in the medical IT services sector. Its rise signals investor doubts about the profitability of this business model or expectations of cuts in R&D budgets in the biotech sector.
Shares shorted by the overall market
iSpecimen is a marketplace that connects researchers with biospecimens (blood, tissue). This chart illustrates the overall market pessimism. Investors fear that during the crisis, biotech and pharmaceutical companies (iSpecimen's clients) will cut their R&D budgets, leading to a decline in demand for research biospecimens.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator iSpecimen Inc. (ISPC)
This chart for iSpecimen is a barometer of the biospecimen market. The company operates an online marketplace connecting researchers (pharmaceutical companies) with hospitals that have tissue and blood samples. "Overheating" (above 70) occurs due to news of an increase in the number of transactions on the platform. Slow adoption and complex biospecimen logistics lead to "oversold" conditions.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-iSpecimen-Inc.-ISPC&v=1772572106654 "RSI 14 indicator chart for the company's stock iSpecimen Inc. (ISPC)")
RSI 14 Market Segment - It med
iSpecimen (ISPC) is the "Amazon" of *bio-specimens*. Their *online marketplace* (SaaS) *connects* *scientists* (R&D) with *hospitals* that have *tissue* and *blood* from patients (for research). The "It med" (medical IT/biotech) sector thrives on "hype." RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is ISPC's growth a niche or a general "hype"?
RSI 14 for the overall market
iSpecimen (ISPC) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ISPC (iSpecimen Inc.)
iSpecimen is a marketplace that connects biotech and pharmaceutical companies in need of biospecimens (blood, tissue) with hospitals that can provide them. This chart shows the analysts' average 12-month forecast. It reflects their view on biotech R&D budgets and iSpecimen's ability to scale its network.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ISPC-iSpecimen-Inc.&v=1772572106745 "A chart showing analyst consensus forecasts for the expected stock price. ISPC (iSpecimen Inc.)")
The difference between the consensus estimate and the actual stock price ISPC (iSpecimen Inc.)
iSpecimen is a marketplace for science. Their platform connects researchers (Big Pharma, biotech) with hospitals, providing access to patient biospecimens (blood, tissue). This chart shows the upside and downside potential analysts see in a stock. It measures the gap between the price and forecast, reflecting their faith in this R&D model.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ISPC-iSpecimen-Inc.&v=1772572106760 "A chart showing the difference between the consensus forecast and the actual stock price. ISPC (iSpecimen Inc.)")
Analyst consensus forecast for stock prices by market segment - It med
iSpecimen is the "eBay" of science. The platform connects biotech companies seeking samples (blood, tissue) for R&D with hospitals that provide them. This chart shows analysts' general expectations for the entire medical IT sector. It reflects whether experts believe R&D budgets in "big pharma" will grow.
Analysts' consensus forecast for the overall market share price
iSpecimen is a marketplace for science. Their platform connects biotechs and pharmaceutical companies (who need samples) with hospitals (who have them). This chart shows overall market sentiment. For iSpecimen, whose business fuels R&D in the defense sector, the overall optimism is important because it reflects the risk appetite and funding of their biotech clients.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index iSpecimen Inc.
iSpecimen is the Amazon of biospecimens. It's a marketplace that connects hospitals (which have surplus blood and tissue) with biotech companies (which need these samples for R&D). They don't own the samples; they're a bridge. This chart is a summary indicator of their transaction model. It reflects their ability to digitize this old, analog marketplace and their reliance on R&D budgets.
AKIMA Market Segment Index - It med
iSpecimen (ISPC) is not a lab, but a marketplace. Their technology platform connects scientists and researchers (who need samples) with hospitals and biobanks (who have them). The chart shows the average index for the segment, helping investors assess the relevance of this aggregator model in IT-Med compared to the average.
The AKIM Index for the overall market
iSpecimen is an online marketplace that connects researchers with suppliers of human biological samples (biobanks, hospitals). This chart, reflecting the market average, provides context. It helps assess how this technological intermediary for science compares to overall macroeconomic trends and R&D budgets.
